victoria blue bo has been researched along with verapamil in 1 studies
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burrow, SM; Phoenix, DA; Wainwright, M; Waring, JJ | 1 |
1 other study(ies) available for victoria blue bo and verapamil
| Article | Year |
|---|---|
Reduced cellular glutathione levels do not affect the cytotoxicity or photocytotoxicity of the cationic photosensitiser Victoria Blue BO.
Topics: Animals; Buthionine Sulfoximine; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Free Radicals; Glutamate-Cysteine Ligase; Glutathione; Mice; Photosensitizing Agents; Quaternary Ammonium Compounds; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Verapamil | 2000 |